Kevin Dang
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
-
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 10
- CAR-T cell therapy research 10
-
- Monoclonal and Polyclonal Antibodies Research 9
- Co-authors
- Ute Schellenberger (12 shared papers)Wim van Schooten (11 shared papers)Duy Pham (11 shared papers)Harshad S. Ugamraj (11 shared papers)Suhasini Iyer (9 shared papers)Katherine E. Harris (9 shared papers)Ben Buelow (11 shared papers)Udaya S. Rangaswamy (7 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)mAbs (3 papers)Blood (1 paper)Neurology (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- United StatesFranceIndia
In The Last Decade
Kevin Dang
12 papers receiving 169 citations
Peers
Comparison fields: 5 of 29
- Radiology, Nuclear Medicine and Imaging 111
- Oncology 120
- Hematology 30
- Immunology 56
- Physiology 9
Countries citing papers authored by Kevin Dang
This map shows the geographic impact of Kevin Dang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Dang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Dang more than expected).
Fields of papers citing papers by Kevin Dang
This network shows the impact of papers produced by Kevin Dang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Dang. The network helps show where Kevin Dang may publish in the future.
Co-authors
The 25 scholars most cited alongside Kevin Dang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 83 | |
| 2 | 2021 | 23 | |
| 3 | 2022 | 19 | |
| 4 | 2018 | 19 | |
| 5 | 2021 | 9 | |
| 6 | 2019 | 6 | |
| 7 | 2018 | 5 | |
| 8 | 2017 | 5 | |
| 9 | 2018 | 4 | |
| 10 | 2018 | 2 | |
| 11 | 2019 | 2 | |
| 12 | 2020 | 1 | |
| 13 | 2025 | 0 | |
| 14 | 2025 | 0 |
About Kevin Dang
Kevin Dang is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Immunology, Molecular Biology and Physiology, having authored 14 papers that have together received 178 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Biosimilars and Bioanalytical Methods (4 papers), Glycosylation and Glycoproteins Research (3 papers), Toxin Mechanisms and Immunotoxins (2 papers), Calcium signaling and nucleotide metabolism (2 papers), Prostate Cancer Treatment and Research (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (111 citations), Oncology (120 citations), Hematology (30 citations), Immunology (56 citations) and Physiology (9 citations). Kevin Dang has collaborated with scholars based in United States, France and India. Frequent co-authors include Ute Schellenberger, Wim van Schooten, Duy Pham, Harshad S. Ugamraj, Suhasini Iyer, Katherine E. Harris, Ben Buelow, Udaya S. Rangaswamy, Starlynn Clarke and Nathan D. Trinklein. Their work appears in journals such as Journal of Clinical Oncology, mAbs, Blood, Neurology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.